Another reported [36] indicated that the co-occurrence of tumor-associated CD8+ T cells and CD20+ B cells is associated with the formation of tertiary lymphoid structures in melanoma and improved immunotherapy and survival. The gene discussed is CD8A; the disease is neoplasm.